✦ LIBER ✦

57LBA Aprepitant (APR) for the prevention of chemotherapy-induced nausea and vomiting (CINV) associated with moderately emetogenic chemotherapy (MEC) in breast and non-breast cancers

✍ Scribed by R. Gralla; B. Rapoport; C. Brown; J.C. Street; J.S. Hardwick; A.D. Carides

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

9048 Aprepitant for the prevention of ch

✍ Rapoport, B.; Boice, J.A.; Brown, C.; Street, J.C.; Hardwick, J.S.; Carides, A.D 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 67 KB

Cost-Effectiveness of Aprepitant for the

✍ Susan Moore; John Tumeh; Steven Wojtanowski; Christopher Flowers 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 743 KB

A randomized study of aprepitant, ondans

✍ Winnie Yeo; F. K. F. Mo; J. J. S. Suen; W. M. Ho; S. L. Chan; W. Lau; J. Koh; W. 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 184 KB

A randomized phase II study of aprepitan

✍ W. Yeo; F.K.F. Mo; J.J.S. Suen; W.M. Ho; S.L. Chan; W.K. Yeung; W. Lau; K.K.C. L 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Effectiveness of palonosetron for preven

✍ Murakami, Michiyasu; Hashimoto, Hiroki; Yamaguchi, Kyohei; Yamaguchi, Ikuko; Sen 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 180 KB

Aprepitant for the prevention of chemoth

✍ Bernardo L. Rapoport; Karin Jordan; Judith A. Boice; Arlene Taylor; Carole Brown 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 174 KB